Universal Health Services, Inc.
225.30+5.98 (+2.73%)
Oct 29, 4:00:01 PM EDT · NYSE · UHS · USD
Key Stats
Market Cap
14.34BP/E (TTM)
10.72Basic EPS (TTM)
21.02Dividend Yield
0%Recent Filings
8-K
8-K
Lawsuit verdict hits UHS subsidiary
Universal Health Services' subsidiary UHS of Delaware lost a lawsuit over physician departures from St. Mary's Medical Group in 2021, with a jury awarding $4.7 million in compensatory damages and $500 million in punitive damages on September 26, 2025. Nevada law caps punitives at about $14 million, though further reductions may apply. The verdict could materially harm finances if appeals fail. UHS plans to challenge it vigorously.
10-Q
Q2 FY2025 results
Universal Health Services posted solid Q2 FY2025 results, with net revenues climbing 9.6% year-over-year to $4.3B, driven by 8.4% same-facility growth across acute care and behavioral health segments; operating income rose 14.7% to $500M, while diluted EPS attributable to UHS jumped 27.5% to $5.43 (derived). Behavioral health revenues surged 8.9% to $1.9B, buoyed by UK facilities at $247M, while acute care added $222M overall, including contributions from new hospitals in Nevada and D.C. Free cash flow, calculated as $909M operating cash minus $505M capex, delivered $404M for the half-year, supporting $379M in share repurchases amid $138M cash on hand. Total debt stands at $4.6B with $1.1B revolver availability, but litigation risks like the Cumberland case loom large.
8-K
UHS boosts Q2 earnings, guidance
Universal Health Services reported Q2 2025 net income of $353.2 million, or $5.43 per diluted share, up from $289.2 million last year, driven by 9.6% revenue growth to $4.284 billion amid Medicaid reimbursements and a new D.C. hospital's $25 million loss. Acute care revenues rose 7.9% on same-facility basis; behavioral health climbed 8.9%. The company raised its full-year forecast to $20.00-$21.00 adjusted EPS. Yet Medicaid changes loom large.
8-K
Annual meeting elects directors
Universal Health Services stockholders convened virtually on May 14, 2025, electing Warren J. Nimetz and Maria R. Singer to the board for three-year terms ending in 2028, with Nimetz receiving unanimous Class A and C support while Singer drew mixed Class B and D votes. They ratified PricewaterhouseCoopers as auditors for the year ending December 31, 2025, in a landslide. Yet the push for annual director elections failed decisively. Governance stays steady.
ACHC
Acadia Healthcare Company, Inc.
23.01-0.16
ARDT
Ardent Health, Inc.
15.01-0.08
CYH
Community Health Systems, Inc.
4.21+0.09
EHC
Encompass Health Corporation
125.63-0.65
HCA
HCA Healthcare, Inc.
468.40+1.94
HCSG
Healthcare Services Group, Inc.
18.81-0.42
NHC
National HealthCare Corporation
120.85-1.15
NUTX
Nutex Health Inc.
127.83-0.85
THC
Tenet Healthcare Corporation
209.14+4.52
UHT
Universal Health Realty Income
36.41-0.79